Frovatriptan Succinate - CAS 158930-09-7
Catalog number: 158930-09-7
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
5-HT Receptor
Thesuccinate salt form of Frovatriptan, a carbazole derivative, has been found to be a 5-HT receptor agonist that could be used as an antimigraine agent.
Frovatriptan succinate; (3R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide butanedioate;1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (3R)-, butanedioate (1:1);Sb-209509ax;Vml 251
Store in a cool and dry place and at 0 - 4 °C for short term (days to weeks) or -20 °C for long term (months to years).
Quality Standard:
In-house standard
Canonical SMILES:
1.[Frovatriptan possibly causing acute myocardial infarction].
Møller-Helgestad OK1, Kaltoft AK, Kasch H. Ugeskr Laeger. 2015 Mar 23;177(13):V10140537.
Globally migraine affects more than 10% of the adult population and it is treated with simple analgesics, combined with a triptan for a stronger treatment effect. Triptans cause arterial vasoconstriction, and this is a case report of vasospasm-induced acute myocardial infarction in a 61-year-old woman with frequent episodic migraine attacks treated with triptans. She was possibly also suffering from medication overuse headache. We suggest that regular frovatriptan use may have contributed to the myocardial infarction and that long-term triptan use may have caused the medication overuse headache.
2.Variability of the characteristics of a migraine attack within patients.
Viana M1, Sances G2, Ghiotto N2, Guaschino E2, Allena M2, Nappi G2, Goadsby PJ3, Tassorelli C4. Cephalalgia. 2015 Oct 23. pii: 0333102415613612. [Epub ahead of print]
BACKGROUND: Migraine attacks may present different features in different patients and also within the same patient. The percentage of patients reporting stereotyped attacks and those reporting attacks with different phenotypes has not been the object of specific investigations.
3.Factors associated with frovatriptan response in patients with migraine: A prospective, observational study.
Seo JG1, Park SP2. Cephalalgia. 2015 Jul 13. pii: 0333102415596443. [Epub ahead of print]
BACKGROUND: Almost one-third of patients with migraine do not adequately respond to triptans. We examined factors contributing to frovatriptan response in patients with migraine.
4.The therapeutic armamentarium in migraine is quite elderly.
Martelletti P1. Expert Opin Drug Metab Toxicol. 2015 Feb;11(2):175-7. doi: 10.1517/17425255.2015.982089. Epub 2014 Dec 1.
Global Burden of Disease 2010 study considers migraine as one of the most important noncommunicable diseases in the world, classifying it third in terms of global prevalence (14.70%): it sums up the 54.19% of all the years of life lived with disabilities caused by the rest of all neurological disorders. This Editorial provides an historical excursus of old and new-entry molecules in migraine therapeutic area. Drugs for acute treatment such as triptans date back to the early 1990s with the appearance of sumatriptan and the following six triptans in the years immediately after (zolmitriptan, rizatriptan, naratriptan, eletriptan, almotriptan, frovatriptan). Prophylaxis drugs, dedicated to patients with medium/high frequency of crises, show as last entries topiramate and botulinum toxin type A. The use of this preventative group, with its intrinsic limits, is mandatory to reduce the risk of migraine chronification, a highly harmful clinical phenomenon that produces as its natural consequence the medication overuse headache.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related 5-HT Receptor Products

CAS 105565-55-7 BMY 14802 hydrochloride

BMY 14802 hydrochloride
(CAS: 105565-55-7)

BMY 14802 hydrochloride is a potent sigma receptor antagonist (IC50 = 112 nM) with weak affinity for 5-HT1A and α1 receptors. BMY 14802 is potentially used as a...

CAS 122883-93-6 Ziprasidone Hydrochloride

Ziprasidone Hydrochloride
(CAS: 122883-93-6)

The hydrochloride salt form of Ziprasidone which is an antagonism of both serotonin and dopamine receptor and could be effective against schizophrenia.

CAS 192927-92-7 LY310762

(CAS: 192927-92-7)

LY310762 has a higher affinity for the guinea pig 5-HT1D receptor than for the 5-HT1B receptor. LY310762 potentiates the potassium-induced [3H]5-HT outflow from...

CAS 1197334-04-5 SB 206553 hydrochloride

SB 206553 hydrochloride
(CAS: 1197334-04-5)

SB 206553 hydrochloride is a potent and selective 5-HT2B/5-HT2C receptor antagonist (rat 5-HT2B pA2 = 8.89, human 5-HT2C pKi = 7.92) with > 80-fold selectivity ...

CAS 1173022-77-9 BRL 15572 hydrochloride

BRL 15572 hydrochloride
(CAS: 1173022-77-9)

BRL 15572 hydrochloride is a selective h5-HT1D antagonist with 60-fold selectivity over h5-HT1B.

CAS 448904-47-0 WY 45233 succinate

WY 45233 succinate
(CAS: 448904-47-0)

WY 45233 succinate is an inhibitor of serotonin and noradrenalin reuptake (SNRI) used in the treatment of major depressive disorder (MDD). WY 45233 succinate in...

CAS 121679-13-8 Naratriptan

(CAS: 121679-13-8)

Naratriptan, a 5-HT1B/1D receptor agonist, could be used in the treatment of migraine.

CAS 172895-15-7 LY 272015 hydrochloride

LY 272015 hydrochloride
(CAS: 172895-15-7)

LY 272015 hydrochloride is a selective 5-HT2B receptor antagonist.

CAS 5560-59-8 Alverine Citrate

Alverine Citrate
(CAS: 5560-59-8)

Alverine Citrate is a highly potent competitive CXCR4 antagonist with EC50 of 0.3 nM.

CAS 186544-26-3 LY 344864

LY 344864
(CAS: 186544-26-3)

LY 344864 is a brain penetrant, full agonist that specifically targets 5-HT1F receptor (pKi = 8.2) with > 80-fold selectivity over other serotonin receptors (Ki...

CAS 634908-75-1 WAY-100635 maleate

WAY-100635 maleate
(CAS: 634908-75-1)

WAY-100635 maleate is a potent and selective 5-hydroxytryptamine1A antagonist for 5-HT ( IC50= 0.95 ± 0.12 nM ), and also exhibits agonist activity at dopamine ...

Risperidone hydrochloride
(CAS: 666179-74-4)

Risperidone is a serotonin 5-HT2 receptor blocker and a potent dopamine D2 receptor antagonist.

CAS 185259-85-2 GR 46611

GR 46611
(CAS: 185259-85-2)

GR 46611 is a 5-HT1D receptor agonist that may be beneficial for the treatment of migraine. 5-HT1D acts on the central nervous system.

CAS 1049747-87-6 SB-242084 HCl salt

SB-242084 HCl salt
(CAS: 1049747-87-6)

SB-242084 is a psychoactive drug and research chemical which acts as a selective antagonist for the 5HT2C receptor. It can increase the effectiveness of the sel...

CAS 152239-46-8 SB 204741

SB 204741
(CAS: 152239-46-8)

SB 204741 is a potent and selective 5-HT2B receptor antagonist (pA2 = 7.95) with ≥ 135-fold selectivity over 5-HT2C (pKi = 5.82), 5-HT2A (pKi < 5.2), 5-HT1A, 1D...

CAS 1197333-95-1 RO 04-6790 hydrochloride

RO 04-6790 hydrochloride
(CAS: 1197333-95-1)

RO 04-6790 hydrochloride is a potent and selective serotonin 5-HT6 receptor antagonist.

CAS 139290-65-6 MDL 100907

MDL 100907
(CAS: 139290-65-6)

MDL 100907 is a selective 5-HT2A receptor antagonist with Ki value of 0.36 nM. It shows antipsychotic activity, attenuates impulsivity, and augments antidepress...

CAS 879089-64-2 CP 93129 dihydrochloride

CP 93129 dihydrochloride
(CAS: 879089-64-2)

The hydrochloride salt form of CP 93129, which is a 5HT1B agonist and exhibits activities in decreasing body weight as well as reducing food intake in rats.

CAS 1977-08-8 Isoclozapine

(CAS: 1977-08-8)

Isoclozapine is a 2-Cl analogue of clozapine as a typical antipsychotic.

Elzasonan citrate
(CAS: 361343-20-6)

Elzasonan citrate is a selective 5-hydroxytryptamine 1B receptor antagonist for treat patients with major depressive disorder and obsessive compulsive disorder.

Chemical Structure

CAS 158930-09-7 Frovatriptan Succinate

Quick Inquiry

Verification code

Featured Items